141 related articles for article (PubMed ID: 2496524)
41. Intestinal metaplasia of the stomach and esophagus: an immunohistochemical study of 60 cases including comparison with normal and inflamed intestinal mucosa.
Chlumská A; Mukenšnabl P; Mareček P; Zámečník M
Cesk Patol; 2014 Jul; 50(3):141-8. PubMed ID: 25186595
[TBL] [Abstract][Full Text] [Related]
42. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
Shearer C; Going J; Neilson L; Mackay C; Stuart RC
Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
[TBL] [Abstract][Full Text] [Related]
43. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
44. Controversies of the cardiac mucosa and Barrett's oesophagus.
Chandrasoma P
Histopathology; 2005 Apr; 46(4):361-73. PubMed ID: 15810947
[TBL] [Abstract][Full Text] [Related]
45. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
46. The relationship of endocrine cells, dysplasia and carcinoembryonic antigen in Barrett's mucosa to adenocarcinoma of the oesophagus.
Griffin M; Sweeney EC
Histopathology; 1987 Jan; 11(1):53-62. PubMed ID: 2881873
[TBL] [Abstract][Full Text] [Related]
47. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study.
Levine DS; Rubin CE; Reid BJ; Haggitt RC
Lab Invest; 1989 Mar; 60(3):418-32. PubMed ID: 2927081
[TBL] [Abstract][Full Text] [Related]
48. Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach.
Glickman JN; Shahsafaei A; Odze RD
Am J Surg Pathol; 2003 Oct; 27(10):1357-65. PubMed ID: 14508397
[TBL] [Abstract][Full Text] [Related]
49. Role of intragastric and intraoesophageal alkalinisation in the genesis of complications in Barrett's columnar lined lower oesophagus.
Attwood SE; Ball CS; Barlow AP; Jenkinson L; Norris TL; Watson A
Gut; 1993 Jan; 34(1):11-5. PubMed ID: 8432439
[TBL] [Abstract][Full Text] [Related]
50. Intestinal metaplasia in Barrett's oesophagus may be an epiphenomenon rather than a preneoplastic condition, and CDX2-positive cardiac-type epithelium is associated with minute Barrett's tumour.
Watanabe G; Ajioka Y; Takeuchi M; Annenkov A; Kato T; Watanabe K; Tani Y; Ikegami K; Yokota Y; Fukuda M
Histopathology; 2015 Jan; 66(2):201-14. PubMed ID: 25040564
[TBL] [Abstract][Full Text] [Related]
51. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
Fléjou JF
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
[TBL] [Abstract][Full Text] [Related]
52. Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus.
Labouvie C; Machado JC; Carneiro F; Sarbia M; Vieth M; Porschen R; Seitz G; Blin N
J Cancer Res Clin Oncol; 1999; 125(2):71-6. PubMed ID: 10190312
[TBL] [Abstract][Full Text] [Related]
53. Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
World J Gastroenterol; 2005 Oct; 11(40):6360-5. PubMed ID: 16419166
[TBL] [Abstract][Full Text] [Related]
54. Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus.
Iftikhar SY; Steele RJ; Watson S; James PD; Dilks K; Hardcastle JD
Gut; 1992 Jun; 33(6):733-7. PubMed ID: 1624150
[TBL] [Abstract][Full Text] [Related]
55. Barrett's oesophagus: mucin composition, neuroendocrine cells, p53 protein, cellular proliferation and differentiation.
Jaskiewicz K; Louw J; Anichkov N
Anticancer Res; 1994; 14(5A):1907-12. PubMed ID: 7847825
[TBL] [Abstract][Full Text] [Related]
56. Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.
Hornick JL; Blount PL; Sanchez CA; Cowan DS; Ayub K; Maley CC; Reid BJ; Odze RD
Am J Surg Pathol; 2005 Mar; 29(3):372-80. PubMed ID: 15725807
[TBL] [Abstract][Full Text] [Related]
57. [The peculiarities of esophageal epithelium of the vertebrates in phylogenesis and Barrett's esophagus].
Mogil'naia GM; Driaeva LG; Durleshter VM; Mogil'naia VL
Morfologiia; 2010; 137(3):41-5. PubMed ID: 20960713
[TBL] [Abstract][Full Text] [Related]
58. Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett's esophagus).
Gottfried MR; McClave SA; Boyce HW
Am J Clin Pathol; 1989 Dec; 92(6):741-6. PubMed ID: 2589244
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
[TBL] [Abstract][Full Text] [Related]
60. Columnar lined oesophagus and intestinal metaplasia: current concepts.
Wolf C; Timmer R; Breumelhof R; Seldenrijk CA; Smout AJ
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):793-800. PubMed ID: 10445803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]